| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.096 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |